MEP11708A - Dimethoxy docetaxel acetone solvate et method for the preparation thereof - Google Patents

Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Info

Publication number
MEP11708A
MEP11708A MEP-117/08A MEP11708A MEP11708A ME P11708 A MEP11708 A ME P11708A ME P11708 A MEP11708 A ME P11708A ME P11708 A MEP11708 A ME P11708A
Authority
ME
Montenegro
Prior art keywords
preparation
acetone solvate
dimethoxy
dimethoxy docetaxel
docetaxel acetone
Prior art date
Application number
MEP-117/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Eric Didier
Marc-Antoine Perrin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP11708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MEP11708A publication Critical patent/MEP11708A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
MEP-117/08A 2003-09-19 2004-09-16 Dimethoxy docetaxel acetone solvate et method for the preparation thereof MEP11708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PCT/FR2004/002344 WO2005028462A1 (fr) 2003-09-19 2004-09-16 Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (1)

Publication Number Publication Date
MEP11708A true MEP11708A (en) 2010-06-10

Family

ID=34224354

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2008-117A ME00054B (me) 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje
MEP-117/08A MEP11708A (en) 2003-09-19 2004-09-16 Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2008-117A ME00054B (me) 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje

Country Status (38)

Country Link
US (1) US7241907B2 (da)
EP (1) EP1667986B1 (da)
JP (1) JP5010279B2 (da)
KR (1) KR101123588B1 (da)
CN (1) CN100429207C (da)
AR (1) AR045667A1 (da)
AU (1) AU2004274212B2 (da)
BE (1) BE2013C036I2 (da)
BR (1) BRPI0414492A8 (da)
CA (1) CA2539309A1 (da)
CR (1) CR8292A (da)
CY (2) CY1114575T1 (da)
DK (1) DK1667986T3 (da)
ES (1) ES2403149T4 (da)
FR (1) FR2859996B1 (da)
HK (1) HK1093340A1 (da)
HR (1) HRP20130322T1 (da)
HU (1) HUS1300025I1 (da)
IL (1) IL174240A (da)
LU (1) LU92172I2 (da)
MA (1) MA28045A1 (da)
ME (2) ME00054B (da)
MX (1) MXPA06002639A (da)
MY (1) MY136668A (da)
NO (2) NO335997B1 (da)
NZ (1) NZ545835A (da)
PA (1) PA8612401A1 (da)
PE (1) PE20050870A1 (da)
PL (1) PL1667986T3 (da)
PT (1) PT1667986E (da)
RS (2) RS20060189A (da)
RU (1) RU2342373C2 (da)
SI (1) SI1667986T1 (da)
TN (1) TNSN06086A1 (da)
TW (1) TWI382022B (da)
UA (1) UA87115C2 (da)
WO (1) WO2005028462A1 (da)
ZA (1) ZA200602255B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
WO2010019233A1 (en) 2008-08-11 2010-02-18 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
CA2779009A1 (en) * 2009-10-29 2011-05-05 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
JP2014514306A (ja) 2011-04-12 2014-06-19 プラス・ケミカルス・エスアー 固体形態のカバジタキセル及びその製造方法
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103906747A (zh) 2011-10-31 2014-07-02 台湾神隆股份有限公司 卡巴他赛及其中间体的制备方法
DE112012004569T5 (de) 2011-11-01 2014-08-14 Fresenius Kabi Oncology Ltd. Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
EP2785701B1 (en) 2011-11-28 2019-01-02 Fresenius Kabi Oncology Limited Crystalline form of carbazitaxel and process for preparation thereof
WO2013088335A1 (en) 2011-12-13 2013-06-20 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
WO2013111157A1 (en) * 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
WO2013117683A1 (en) * 2012-02-10 2013-08-15 Aventis Pharma S.A. New pediatric uses of cabazitaxel
EP2822932A2 (en) 2012-03-08 2015-01-14 IVAX International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) * 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
US9012665B2 (en) 2012-07-31 2015-04-21 Yung Shin Pharm. Ind. Co., Ltd. Amorphous cabazitaxel
EP2884963B1 (en) 2012-08-15 2017-12-27 Yung Shin Pharm. Ind. Co. Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
EP3247350B1 (en) 2015-01-12 2021-12-22 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
JP6841772B2 (ja) * 2015-02-17 2021-03-10 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム 前立腺癌の処置におけるカバジタキセルの使用
EP3093014A1 (en) 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
IL301470A (en) 2016-11-29 2023-05-01 Ptc Therapeutics Mp Inc Polymorphs of spiafatrin and its salts
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CN112703002A (zh) 2018-05-30 2021-04-23 Ptc医疗Mp公司 增加墨蝶呤血浆暴露的方法
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
ES2211550T3 (es) * 1999-05-17 2004-07-16 Bristol-Myers Squibb Company Nuevas condiciones de reaccion para la escision de eteres de sililo en la preparacion de paclitaxel (taxol(r)) y analogos de paclitaxel.
CA2468953C (en) * 2001-11-29 2010-05-11 Daiichi Pharmaceutical Co., Ltd. Taxane derivative crystal and method for preparing the same

Also Published As

Publication number Publication date
NO2015013I2 (no) 2015-04-22
RU2006113122A (ru) 2006-08-27
US20050065138A1 (en) 2005-03-24
HK1093340A1 (en) 2007-03-02
AU2004274212B2 (en) 2010-03-04
TNSN06086A1 (en) 2007-10-03
AU2004274212A1 (en) 2005-03-31
WO2005028462A1 (fr) 2005-03-31
NO335997B1 (no) 2015-04-20
CY1114575T1 (el) 2016-10-05
TW200524891A (en) 2005-08-01
FR2859996A1 (fr) 2005-03-25
BE2013C036I2 (da) 2023-12-14
CN1849311A (zh) 2006-10-18
TWI382022B (zh) 2013-01-11
ZA200602255B (en) 2007-07-25
CY2013016I1 (el) 2018-01-10
PL1667986T3 (pl) 2013-06-28
HUS1300025I1 (hu) 2016-08-29
NZ545835A (en) 2009-10-30
FR2859996B1 (fr) 2006-02-03
RS54614B1 (en) 2016-08-31
BRPI0414492A (pt) 2006-11-14
JP2007505866A (ja) 2007-03-15
LU92172I2 (fr) 2013-05-21
ME00054B (me) 2011-02-10
EP1667986B1 (fr) 2013-01-16
MY136668A (en) 2008-11-28
ES2403149T4 (es) 2013-06-24
CR8292A (es) 2008-10-15
MA28045A1 (fr) 2006-07-03
RS20060189A (en) 2008-06-05
CA2539309A1 (fr) 2005-03-31
NO20061714L (no) 2006-04-19
MXPA06002639A (es) 2006-06-05
SI1667986T1 (sl) 2013-05-31
ES2403149T3 (es) 2013-05-14
IL174240A0 (en) 2006-08-01
JP5010279B2 (ja) 2012-08-29
PE20050870A1 (es) 2005-11-21
DK1667986T3 (da) 2013-05-06
KR101123588B1 (ko) 2012-03-22
UA87115C2 (ru) 2009-06-25
HRP20130322T1 (en) 2013-07-31
LU92172I9 (da) 2019-01-03
RU2342373C2 (ru) 2008-12-27
CY2013016I2 (el) 2018-01-10
IL174240A (en) 2010-12-30
NO2015013I1 (no) 2015-05-04
CN100429207C (zh) 2008-10-29
PA8612401A1 (es) 2005-08-04
KR20060072147A (ko) 2006-06-27
AR045667A1 (es) 2005-11-02
EP1667986A1 (fr) 2006-06-14
BRPI0414492A8 (pt) 2019-01-15
PT1667986E (pt) 2013-04-24
US7241907B2 (en) 2007-07-10

Similar Documents

Publication Publication Date Title
MEP11708A (en) Dimethoxy docetaxel acetone solvate et method for the preparation thereof
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
CY1112781T1 (el) 2'-φθορο-2'-δεοξυτετραϋδροουριδινες ως αναστολεις αποαμινασης κυτιδινης
CY1116373T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
BR112021025928A2 (pt) Métodos de preparação de ácido bempedoico e composições do mesmo
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
CY1110738T1 (el) Παραγωγα aminoαλκυλβενζοϋλ-βενζοφουραν ή βενζοθειοφαιν, μεθοδος παρασκευης τους και συνθεσεις που τα περιεχουν
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
PT1246809E (pt) Compostos de 5-aril-1h-1,2,4-triazole como inibidores de ciclooxigenase-2 e composicoes farmaceuticas que os contem
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
BRPI0408389A (pt) derivados de cromeno como agentes antiinflamatórios
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60335980D1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
EA200300063A1 (ru) Производные аминоалкенилбензоил-бензофурана или бензотиофена, способы их получения и содержащие их композиции
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
AR047175A1 (es) Metodo para el tratamiento de enfermedades pulmonares
ATE394386T1 (de) 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren
ECSP066441A (es) ?15-d-homoesteroides que tienen un efecto androgénico